Basel, 28 September 2015
Invitation to Roche's investor science conference call from ECTRIMS 2015
We kindly invite investors and analysts to participate in a conference call on Monday, 12 October 2015 following the ECTRIMS annual international conference devoted to basic and clinical research in multiple sclerosis 7-10 October 2015 in Barcelona.
On the call, Roche will discuss new data from:
- OPERA I and OPERA II, two Phase III studies designed to evaluate the efficacy and safety of ocrelizumab compared with interferon Β-1a (Rebif) in patients with relapsing multiple sclerosis
- ORATORIO in PPMS
Conference call will start with presentations followed by a Q&A session.
The conference call will take place on:
Monday, 12 October 2015
10:00am - 11:00am CEST / 9:00am - 10:00am BST
4:00am - 5:00am EDT / 1:00am - 2:00am PDT
Investors and analysts are invited to join the conference call either by live audio webcast or by telephone.
+41 (0) 58 310 5000 (Europe and ROW) or
+44 (0) 203 059 5862 (UK) or
+1 (1) 631 570 5613 (USA)
To expedite the registration process on the day of the conference call, you may pre-register for the event by clicking here.
The presentation slides will be available from the IR website at http://ir.roche.com
A replay will be available following the event, for 48 hours. Access is by dialing:
+41 (0) 91 612 4330 (Europe and ROW) or
+44 (0) 207 108 6233 (UK) or
+1 (1) 631 982 4566 (USA)
Please enter the conference ID 13659 followed by the # sign.
A replay of the webcast will be available on demand on the Roche website. click here.